A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...

The request comes amid continuing uncertainty over federal funding, with research and thousands of jobs on the line.

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...